Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,485 | Dovepress* | 4,566+ | 244 | 4,810 | |
| PubMed Central* | 919 | 349 | 1,268 | ||
| Totals | 5,485 | 593 | 6,078 | ||
| *Since 1 November 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar